24/07/2024  00:00:00 Var. +0.50 Volume Denaro17:29:39 Lettera17:29:39 Capitalizzazione di mercato Dividend Y. Rapporto P/E
67.50SEK +0.75% 1.17 mill.
Fatturato: 78.83 mill.
67.65Quantità in denaro: - 67.75Quantità in lettera: - 24.81 bill.SEK 3.57% 19.74

Descrizione business

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Gustaf Salford
Consiglio di amministrazione
Tobias Hägglöv, Jonas Bolander, Anna Conneryd Lundgren, Habib Nehme, Maurits Wolleswinkel, John Lapré
Consiglio di sorveglianza
Laurent Leksell, Birgitta Stymne Göransson, Caroline Leksell Cooke, Cecilia Wikström, Jan Secher, Johan Malmquist, Wolfgang Reim, Kelly Londy
 

Dati aziendali

Name: Elekta AB
Indirizzo: Kungstensgatan 18,S-103 93 Stockholm
Telefono: +46-8-587-254-00
Fax: +46-8-587-255-00
E-mail: info@elekta.com
Internet: www.elekta.com/
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 30/04
Flottante libero: -
Data dell'IPO: -

Rapporti con gli investitori

Name: Cecilia Ketels
IR telefono: +46-707-6381-25
IR Fax: -
IR e-mail: cecilia.ketels@elekta.com

Company calendar

CW 35 | 28/08/2024 Interim Report 1st Quarter/3 Months
CW 36 | 05/09/2024 General Shareholder Meeting
CW 48 | 27/11/2024 Interim Report 2nd Quarter/6 Months
CW 8 | 21/02/2025 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
58.58%
Fourth Swedish National Pension Fund
 
9.06%
Laurent Leksell with company
 
5.72%
T. Rowe Price
 
4.55%
SEB Funds
 
3.75%
Nordea Funds
 
3.69%
Vanguard
 
3.37%
Swedbank Robur Funds
 
3.08%
Handelsbanken Funds
 
3.04%
Altri
 
5.16%